South America Softgel Capsule Market Research Report By Type (Gelatin Type, Non-Animal Type), By Application (Vitamins, Supplement, Nutrition) and By Regional (Brazil, Mexico, Argentina, Rest of South America)-Forecast to 2035

South America Softgel Capsule Market Overview

As per MRFR analysis, the South America Softgel Capsule Market Size was estimated at 375 (USD Million) in 2023. The South America Softgel Capsule Market Industry is expected to grow from 500(USD Million) in 2024 to 900 (USD Million) by 2035. The South America Softgel Capsule Market CAGR (growth rate) is expected to be around 5.489% during the forecast period (2025 - 2035).

Key South America Softgel Capsule Market Trends Highlighted

The South America Softgel Capsule Market is expanding significantly, primarily due to the growing demand for nutraceuticals and dietary supplements among consumers. Consumers are increasingly seeking convenient and effective supplement forms due to the increasing awareness of health and wellness in countries such as Brazil, Argentina, and Colombia. Softgel capsules are the preferred option due to their superior absorption and simplicity of swallowing.

Another significant market driver is the increasing influence of online retail platforms, which increases consumer accessibility and enables a diverse selection of softgel products. In recent years, there has been a substantial increase in the popularity of plant-based and natural ingredients.

The demand for sustainable and ethically produced ingredients is being met by an increased interest in softgel capsules made from vegetarian sources, as consumers in South America become more health-conscious and environmentally aware. This change is creating opportunities for manufacturers to investigate innovative formulations that are consistent with consumer preferences for vegan and organic products.

Additionally, the COVID-19 pandemic has intensified the emphasis on preventive healthcare, thereby increasing the demand for softgel supplements that support the immune system. Companies are recognizing opportunities to address the increasing demand for products that promote immune health and overall well-being as more individuals prioritize their health.

Adherence to these guidelines can provide a competitive advantage for companies in the softgel capsule market as regulations and quality standards continue to evolve in countries throughout South America, particularly in Brazil and Argentina. The utilization of innovative technology in manufacturing processes is also becoming increasingly prevalent, resulting in enhanced product quality and safety. In general, the South America Softgel Capsule Market is characterized by a dynamic landscape that is replete with the potential for growth and innovation, which is being driven by evolving consumer preferences and behaviors.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South America Softgel Capsule Market Drivers

Increasing Demand for Dietary Supplements

The growing health consciousness among consumers in South America is driving the demand for dietary supplements, a significant component of the South America Softgel Capsule Market Industry. According to the Brazilian Ministry of Health, the consumption of dietary supplements has grown by approximately 20% in the last three years, indicating a notable shift towards preventive healthcare. Established organizations such as the Brazilian Association of Nutritional Supplements are promoting awareness around the benefits of supplements, further contributing to the rising demand.

As consumers become more aware of the health benefits associated with softgel capsules, including easier digestion and enhanced bioavailability, this will drive growth in the market for softgel capsules in South America. This trend is also supported by an expanding middle class willing to invest in health-related products, positioning the South America Softgel Capsule Market for substantial growth.

Growth in the Pharmaceutical Sector

The pharmaceutical sector in South America is experiencing significant growth, which directly benefits the South America Softgel Capsule Market Industry. According to the National Agency of Sanitary Surveillance in Brazil, the pharmaceutical market is projected to grow at a CAGR of approximately 6.5% over the next five years due to increased healthcare spending and emphasis on innovative drug delivery systems.

Major pharmaceutical companies, such as Libbs Farmacêutica and EMS, are increasingly adopting softgel capsules for their product lines, as these capsules provide advantages such as improved stability and patient compliance.This growing pharmaceutical landscape will enhance the demand for softgel capsules as a preferred form for medication delivery.

Rising Prevalence of Chronic Diseases

The rising incidence of chronic diseases in South America is a key driver for the South America Softgel Capsule Market. Reports from the Pan American Health Organization indicate that nearly 80% of deaths in the region are due to chronic conditions like heart disease and diabetes. With healthcare systems focusing on effective treatments and management strategies for these diseases, pharmaceutical companies are increasingly looking for innovative delivery methods such as softgel capsules.

This trend is further supported by health programs initiated by organizations like the World Health Organization aimed at improving the management of chronic diseases in member countries. As a result, the demand for softgel capsules to deliver chronic disease medications effectively is expected to increase.

South America Softgel Capsule Market Segment Insights

Softgel Capsule Market Type Insights

The South America Softgel Capsule Market showcases a diversified range of types, primarily divided between Gelatin Type and Non-Animal Type. The Gelatin Type is extensively utilized due to its compatibility with various formulations, being particularly favored for vitamins, dietary supplements, and pharmaceuticals. This type of softgel often holds a majority share in the market due to its long-standing use and consumer acceptance. On the other hand, the Non-Animal Type is rising in prominence owing to the growing trend toward vegetarianism and veganism, addressing demand from consumers who prefer plant-based solutions.

As the South America region becomes increasingly health-conscious, the Non-Animal Type addresses a niche segment within the softgel market by catering to ethical and dietary preferences, thus presenting considerable opportunities for growth. The trends in the South America Softgel Capsule Market indicate a potential shift towards more inclusive options as consumers look for transparency in ingredient sourcing. Additionally, the significant manufacturing capabilities in South America facilitate the production of both Gelatin and Non-Animal types, allowing for tailored solutions that meet various consumer needs.Key drivers for market expansion include increasing investments in health and wellness sectors, coupled with rising awareness of nutritional supplements among the population.

The South America Softgel Capsule Market is also positioned to benefit from technological advancements in capsule production, encouraging innovation and variety within these types. Overall, both types play essential roles in fulfilling the diverse demands of the South American market, with Gelatin Type holding historical significance and Non-Animal Type making substantial inroads in response to contemporary consumer preferences.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Softgel Capsule Market Application Insights

The Application segment of the South America Softgel Capsule Market encompasses critical categories such as Vitamins, Supplement, and Nutrition, which play a vital role in promoting health and wellness across the region. As consumers increasingly prioritize preventive healthcare and the management of chronic diseases, the demand for vitamin and supplement softgel products is on the rise. This shift towards health-conscious choices is prompting manufacturers to innovate and diversify their offerings, ensuring that formulations cater to specific health needs, such as immune support and enhanced nutrient absorption.

Moreover, the growing trend of natural and herbal supplements is further driving the market as consumers seek products with fewer artificial additives. The Nutrition segment is gaining traction as well, with softgel capsules becoming a preferred method for delivering essential nutrients in a convenient form, appealing to busy lifestyles prevalent in urban South America. These factors contribute to the ongoing evolution of the South America Softgel Capsule Market, where the focus on holistic health solutions positions the Application segment as a significant driver of growth and product development in the industry.

Softgel Capsule Market Regional Insights

The South America Softgel Capsule Market exhibits significant diversity across various countries, with Brazil, Mexico, Argentina, and the Rest of South America showcasing their unique market dynamics. Brazil holds a dominant position due to its robust pharmaceutical industry, driven by the country's large population and increasing health consciousness among consumers. Mexico follows closely, characterized by its growing demand for nutraceutical products, which is expected to enhance the Softgel Capsule Market presence.

Argentina's market is bolstered by a rising trend in preventative healthcare, contributing to an uptick in the use of softgels for dietary supplements.Meanwhile, the Rest of South America presents opportunities through emerging economies that are gradually understanding the benefits of softgel capsules in general healthcare.

The overall growth in the South America Softgel Capsule Market is supported by factors such as increasing healthcare spending, rising consumer awareness of health supplements, and a shift toward convenient dosage forms. Each country's specific needs and trends illustrate a broader regional movement toward alternative health solutions, thus shaping the South America Softgel Capsule Market industry landscape.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South America Softgel Capsule Market Key Players and Competitive Insights

The South America Softgel Capsule Market is characterized by a dynamic competitive landscape influenced by an increasing demand for dietary supplements, pharmaceuticals, and nutraceuticals within the region. With the softgel format being favored for its beneficial properties such as easy swallowing and enhanced bioavailability, numerous players are entering the market or expanding their portfolios. These companies focus on innovation, product differentiation, and strategic partnerships to gain competitive advantages. The market is becoming increasingly consolidated, with established players leveraging their distribution networks and manufacturing capabilities to enhance their presence and capture a larger market share.

Additionally, regulatory compliance and the ability to scale production effectively are key factors that dictate success in this sector, making it imperative for companies to maintain robust quality control mechanisms while also investing in research and development.Brenntag stands as one of the key players in the South America Softgel Capsule Market, showcasing a strong presence due to its extensive distribution network that reaches a variety of customers across the region. The company's strengths lie in its ability to provide tailored solutions and exceptional customer service, which helps in fostering long-term relationships with clients in the pharmaceutical and nutraceutical industries.

Brenntag is known for its commitment to quality and compliance with local regulations, making it a preferred choice among manufacturers looking for reliable partners. The company continually invests in advancing its capabilities and enhancing its supply chain logistics, which enhances its competitive edge in the South American market.Alcami Corporation also plays a significant role in the South America Softgel Capsule Market by offering a wide range of services, including drug development and manufacturing solutions tailored for the pharmaceuticals and biotechnology sectors. Known for its focus on quality and innovation, Alcami has established a strong foothold in the region, providing both contract manufacturing and product development services.

The company’s strengths include its state-of-the-art facilities and an experienced workforce committed to ensuring compliance with regulatory standards. Alcami has made strategic investments in its capabilities, which include expanding its service offerings through mergers and acquisitions in response to market trends. This proactive approach enables Alcami to stay competitive and meet the evolving needs of its clients in the South American softgel capsule sector.

Key Companies in the South America Softgel Capsule Market Include

• Brenntag


• Alcami Corporation


• Licaps


• Lonza


• Kerry Group


• BASF


• Bausch Health Companies


• SABIC


• Gallery Pharmaceuticals


• Catalent


• Pfizer


• Amgen


• Cognis


• Softgel Technologies


• Bayer

South America Softgel Capsule Market Industry Developments

In recent months, the South America Softgel Capsule Market has witnessed notable developments amid its growing demand. Key players such as Brenntag, Lonza, and Catalent are expanding their operations to cater to the burgeoning nutraceutical industry, particularly as Brazil and Argentina show increasing consumption of dietary supplements. Additionally, the market is seeing a shift towards collaborations and strategic partnerships to enhance product offerings and manufacturing capabilities.

For instance, in September 2023, Alcami Corporation completed a merger with a local firm to bolster its presence in the region. This move aligns with the rising trend of local companies seeking alliances with established global entities like Pfizer and Kerry Group.

The market is also experiencing significant valuation growth, driven by the rising popularity of softgel formulations for pharmaceuticals and vitamins. The 2022 launch of new softgel products by Bausch Health Companies aimed at addressing chronic health issues marked a notable event in the market. Current affairs indicate a strong focus on innovation and the sustainability of softgel manufacturing processes, reflecting a shifting consumer preference towards more eco-friendly options in Brazil and beyond.

South America Softgel Capsule Market Segmentation Insights

Softgel Capsule Market Type Outlook

• Gelatin Type


• Non-Animal Type

Softgel Capsule Market Application Outlook

• Vitamins


• Supplement


• Nutrition

Softgel Capsule Market Regional Outlook

• Brazil


• Mexico


• Argentina


• Rest of South America

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	375.0(USD Million)
MARKET SIZE 2024	500.0(USD Million)
MARKET SIZE 2035	900.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.489% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Brenntag, Alcami Corporation, Licaps, Lonza, Kerry Group, BASF, Bausch Health Companies, SABIC, Gallery Pharmaceuticals, Catalent, Pfizer, Amgen, Cognis, Softgel Technologies, Bayer
SEGMENTS COVERED	Type, Application, Regional
KEY MARKET OPPORTUNITIES	Rising demand for dietary supplements, Growth in pharmaceutical applications, Increasing health consciousness among consumers, Expansion of e-commerce distribution channels, Innovative softgel formulations and technologies
KEY MARKET DYNAMICS	rising healthcare expenditure, increasing demand for dietary supplements, growing aging population, advancements in drug delivery systems, strong preference for plant-based products
COUNTRIES COVERED	Brazil, Mexico, Argentina, Rest of South America